These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 7730714

  • 1. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P, Manimozhi N, Jesudasan K.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [Abstract] [Full Text] [Related]

  • 2. Incidence of "chance" smear positivity among MB leprosy patients after MDT.
    Vijayakumaran P, Manimozhi N, Jesudasan K.
    Indian J Lepr; 1995 Mar; 67(3):249-58. PubMed ID: 8576604
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 4. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK, Girdhar A, Natrajan M, Kumar A, Girdhar BK.
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [Abstract] [Full Text] [Related]

  • 5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 6. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
    Gelber RH, Balagon VF, Cellona RV.
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
    [Abstract] [Full Text] [Related]

  • 7. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS, Bhanage ND, Sawant KV, Ganapati R.
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [Abstract] [Full Text] [Related]

  • 8. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 10. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
    Vijayakumaran P, Jesudasan K, Manimozhi N.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
    [Abstract] [Full Text] [Related]

  • 11. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [Abstract] [Full Text] [Related]

  • 12. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK, Sharma P.
    Indian J Lepr; 2008 Sep; 80(3):247-55. PubMed ID: 19432355
    [Abstract] [Full Text] [Related]

  • 13. Minocycline in lepromatous leprosy.
    Fajardo TT, Villahermosa LG, dela Cruz EC, Abalos RM, Franzblau SG, Walsh GP.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [Abstract] [Full Text] [Related]

  • 14. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P, Ji B.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
    [Abstract] [Full Text] [Related]

  • 15. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A, Girdhar A, Girdhar BK.
    Acta Leprol; 2003 Dec; 12(3):123-8. PubMed ID: 15040703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.